Il 1Β Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| IL-1β Protein | |
|---|---|
| Protein Name | Interleukin-1 beta |
| Gene | [IL1B](/genes/il1b) |
| UniProt ID | [P01584](https://www.uniprot.org/uniprot/P01584) |
| PDB ID | 1HIB, 1I1B, 2M4D |
| Molecular Weight | 31 kDa (269 aa, pro-form) |
| Subcellular Localization | Secreted, Cytoplasm |
| Protein Family | Interleukin-1 family |
IL-1β Protein is involved in biological pathways relevant to neurodegenerative diseases. It plays important roles in neuronal function, cellular signaling, or stress response mechanisms.
Dysregulation or mutations in this gene/protein contribute to the pathogenesis of Alzheimer's disease, Parkinson's disease, and related neurodegenerative disorders.
IL-1β is synthesized as a 31 kDa pro-form (pro-IL-1β) that requires cleavage by caspase-1 to become biologically active. The mature form (17 kDa) is secreted:
IL-1β is a key pro-inflammatory cytokine mediating innate immune responses:
In the CNS, IL-1β is produced by:
| Approach | Drug/Agent | Status | Mechanism |
|---|---|---|---|
| IL-1 receptor antagonist | Anakinra | FDA approved | Blocks IL-1β signaling |
| IL-1β neutralizing antibody | Canakinumab | FDA approved | Binds and neutralizes IL-1β |
| NLRP3 inflammasome inhibitor | MCC950 | Preclinical | Blocks IL-1β processing |
| IL-1R1 antibody | MEDI-2338 | Clinical | Blocks receptor binding |
The study of Il 1Β Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.